Fed. Circ. Says Biosig Heart Monitor Patent Not Indefinite

Law360, New York (April 27, 2015, 8:23 PM EDT) -- The Federal Circuit ruled once again Monday that a Biosig Instruments Inc. heart rate monitor patent asserted against Nautilus Inc. is not indefinite, reaffirming its earlier decision even under a new indefiniteness standard set by the U.S. Supreme Court last year.

Although the high court last year threw out the Federal Circuit's standard for proving indefiniteness in an appeal by Nautilus, the Federal Circuit ruled that the revised test did not change the outcome of the case.

The justices held the Federal Circuit's old test that...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Biosig Instruments, Inc. v. Nautilus, Inc.


Case Number

12-1289

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

March 26, 2012

Law Firms

Companies

Government Agencies

Patents

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.